Mutations in a set of ancient matrisomal glycoprotein genes across neoplasia predispose to disruption of morphogenetic transduction
Jimpi LangthasaiD, Satyarthi MishraiD, U MonicaiD, Ronak KalaliD, Ramray BhatiD
Abstract
Misexpression and remodeling of the extracellular matrix is a canonical hallmark of cancer, although the extent of cancer-associated aberrations in the genes coding for ECM proteins and consequences thereof, are not well understood. In this study, we examined the alterations in core matrisomal genes across a set of nine cancers. These genes, especially the ones encoding for ECM glycoproteins, were observed to be more susceptible to mutations than copy number variations across cancers. We classified the glycoprotein genes based on the ubiquity of their mutations across the nine cancer groups and estimated their evolutionary age using phylostratigraphy. To our surprise, the ECM glycoprotein genes commonly mutated across all cancers were predominantly unicellular in origin, whereas those commonly showing mutations in specific cancers evolved mostly during and after the unicellular-multicellular transition. Pathway annotation for biological interactions revealed that the most pervasively mutated glycoprotein set regulated a larger set of inter-protein interactions and constituted more cohesive interaction networks relative to the cancer-specific mutated set. In addition, ontological prediction revealed the pervasively mutated set to be strongly enriched for basement membrane dynamics. Our results suggest that ancient unicellular-origin ECM glycoproteins were canalized into playing critical tissue morphogenetic roles, and when disrupted through matrisomal gene mutations, associate with neoplastic transformation of a wide set of human tissues.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- 14th percentile
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A pan-cancer analysis of matrisome proteins reveals CTHRC1and LOXL2 as major ECM regulators across cancers
Keerthi Harikrishnan, Srinivas Sheshagiri Prabhu, Nagaraj Balasubramanian·bioRxiv·Apr 27, 2021
- Cancer malignancy is correlated with up-regulation of PCYT2-mediated glycerol phosphate modification of α-dystroglycan
F. Umezawa, M. Natsume, … K. Kato·bioRxiv·Oct 25, 2021
- Characterizing the extracellular matrix transcriptome of cervical, endometrial, anduterine cancers
C. J. Cook, A. E. Miller, … K. Fogg·bioRxiv·Apr 4, 2022
- The transcriptional landscape of glycosylation-related genes in cancer
E. Rodriguez, D. Lindijer, … Y. van Kooyk·bioRxiv·Sep 28, 2022
- Loss of PGC1α drives extracellular matrix remodelling in prostate cancer through CTHRC1
Alvaro Gonzalo-Paulano, Alice Macchia, … V Torrano·bioRxiv·May 8, 2026
- Evolutionary fingerprints of EMT in pancreatic cancers
L. Perelli, L. Zhang, … G. Genovese·bioRxiv·Sep 18, 2023